Joseph F. Finn, Jr., Assignee for the Benefit of Creditors of EPIX Pharmaceuticals, Inc., Releases Statement Regarding Liquidation Process
22nd October 2009 WELLESLEY HILLS, Massachusetts, October 22 /PRNewswire/ -- The previously announced auction of assets of EPIX Pharmaceuticals, Inc.
was conducted on October 21, 2009. As of today, claims filed...
EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient
16th October 2009 WELLESLEY HILLS, Massachusetts, October 16 /PRNewswire/ -- The FDA has approved a Physician-Sponsored IND and continuation of the
fourth 6-month open label extension of PRX-03140, a novel 5HT4...
Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
13th October 2009 PHILADELPHIA, October 13 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that it has settled all pending
litigation with Sandoz, Inc....
Occlutech Receives Positive Ruling in German Proceeding Initiated by AGA Medical
23rd September 2009 JENA, Germany, September 23 /PRNewswire/ -- Occlutech GmbH, the leading European developer of products for septal
closure, today announced that the district court of Frankfurt, Germany
reversed an...
Drink-Drive Cambridgeshire Vet Warned as to Future Conduct
21st September 2009 LONDON, September 21 /PRNewswire/ -- Following a two-year postponed judgment, the Disciplinary Committee (DC)
of the Royal College of Veterinary Surgeons last week [17 September 2009]
warned a...
Welsh Health Minister's Ban on Advertising in Hospitals Will Cost the NHS GBP1 Million
18th September 2009 LONDON, September 18 /PRNewswire/ -- Health Minister Edwina Hart's directive to ban all legal service
advertising in hospitals could cost the Welsh NHS trusts GBP1 million in
compensation through...
EPIX Pharmaceuticals, Inc. Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered For Sale at the September 30, 2009 Auction
1st September 2009 WELLESLEY HILLS, Massachusetts, September 1 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that the P2Y2
Gastrointestinal Early Development Candidate Program will be part of...
Epix Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics Program in Phase 2 for Respiratory Indication Will Be Part of The Intellectual Property Offered for Sale at the September 30, 2009 Auction
18th August 2009 WELLESLEY HILLS, Massachusetts, August 18 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that the PRX-08066
Therapeutics Program in Phase 2 for respiratory indication will be...
Class Action Notice for Minnesota Light Cigarette Litigation From Lommen, Abdo, Cole, King & Stageberg, P.A.
4th August 2009 MINNEAPOLIS, August 4 /PRNewswire/ -- Court ordered Class Notice in Curtis, et al., v Altria Group, Inc. and
Philip Morris USA, Inc., et al., court File No. 27-CV-01-18042 (action filed
11/28/01).
...
Eli Lilly & Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation
30th July 2009 TAINAN, Taiwan, July 30 /PRNewswire/ -- Eli Lilly & Company ("Lilly") and ScinoPharm Taiwan Ltd. ("ScinoPharm")
announced today that they have reached an amicable resolution of all ongoing
patent...
Glenmark Brings to the Notice of the Authorities Irregularities of the Clinical Investigator at its Jamnagar Site in Gujarat
23rd July 2009 MUMBAI, July 23 /PRNewswire/ -- After receiving approval from the Drug Controller General of India(DCGI)
for a multi-centre Phase IIb clinical study for its lead COPD/asthma
molecule, Oglemilast,...
UK Court of Appeal Rules in Smith & Nephew's Favour
14th July 2009 HULL, England, July 14 /PRNewswire/ -- Smith & Nephew's Advanced Wound Management division (LSE: SN) (NYSE: SNN)
announced that the UK Court of Appeal has ruled as invalid all claims
asserted...
Trimega Laboratories: Drunk Parents Risk Losing Children in Hair Tests
8th July 2009 LONDON, July 8 /PRNewswire/ -- Divorcing parents who embark on a hedonistic lifestyle are in
danger of losing custody of their children thanks to a growing trend in hair
test requests to gauge how...
The Court Supports Bavarian Nordic's Decision to Start Patent Infringement Case Against Oxford BioMedica
9th May 2009 KVISTGARD, Denmark, May 9 /PRNewswire/ -- Oxford Biomedica's second attempt to dismiss Bavarian Nordic's patent
infringement suit in the United States has failed. Instead of denying
infringement,...
Statement From Michael Hansen, CEO of Elsevier's Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005
7th May 2009 PHILADELPHIA, Pennysylvania, May 7 /PRNewswire/ -- Elsevier, one of the world's leading publishers of scientific, technical,
and medical (STM) information products and services, announced today...
Call for Northern Ireland Abortion Guidelines to be Withdrawn
22nd April 2009 BELFAST, Northern Ireland, April 22 /PRNewswire/ -- Pro-life campaigners are calling on Mr Michael McGimpsey MLA, Northern
Ireland's health minister, to withdraw the controversial guidelines...
Gunther Von Hagens' BODY WORLDS and KORPERWELTEN - Not Affiliated With Paris Copycat Display
22nd April 2009 HEIDELBERG, Germany, April 22 /PRNewswire/ -- The Institute for Plastination in Heidelberg, Germany and its Scientific
Director, anatomist Dr. Gunther von Hagens - creators of the world...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
